Listing analysis and research matching Private:
Public-private partnerships for drug development: An emerging trend or special cases?
On November 5th 2007 the pharmaceutical company GlaxoSmithKline announced that it had formed a five year alliance with the Texan based non-profit research institution MD Anderson Cancer Center to discover and develop new therapeutic, diagnostic and imaging products for cancer.
